Contract – H. Pylori C13 Service (Leicester City CCG)
2. Urgent ! OPPORTUNITY NOTICE – PROVISION OF MANAGEMENT OF HELICOBACTER PYLORI C13 UREA BREATH TEST SERVICE for Leicester City Contractors
Please note: This service will not be procured through community pharmacy for East and West Leicestershire CCG.
This is a call for competition.
NHS Leicester City CCG is re-commissioning its Management of Helicobacter Pylori C13 Urea Breath Test Service.
This opportunity is to maintain a wide provider market and patient choice for this service by commissioning this as an AQP contract framework.
The Commissioners wish to receive responses to the Invitation to Tender (ITT) from suitably qualified and experienced Providers with the necessary capacity and capability (or a demonstrable ability to provide the necessary capacity and capability) to provide the range of services required.
Deadline for submission to tender for the service : 12th February 12 noon 2019
Please see the attached letter if you wish for instructions on how to tender for the service – I have been assured it’s a relatively simple Yes / No questionnaire
The contract duration will be for a period of 5 years. ( please ensure you apply before the deadline of 12th February 12 noon )
The ITT will be live on the 18th January 2019 on M&L CSU Bravo portal (see below) and it will have a deadline for submissions of 12:00 on the 12th February 2019. Clarifications may be asked during the procurement process up to a week before the ITT deadline, i.e. the deadline for submitting clarification questions on the tender is 17:00 6th February 2019.
Interested providers are guided to the MLCSU eProcurement portal Bravo at https://mlcsu.bravosolution.co.uk
To register their interest and gain access to this procurement’s documents and more specific information, please see below for instructions on how to register on the portal.
To register on the ML CSU Bravo portal please see instructions in the attached letter below:
To register on the Bravo portal
If your organisation has registered previously, you do not need to re-register.
1) Register on the portal webpage at https://mlcsu.bravosolution.co.uk (registration and use of the website is free of charge).
2) Once registered, candidates must Express their Interest by:
a) logging into the ML CSU eTendering Bravo portal
b) selecting response to ITT_627,
c) select Open Access ITT_627,
d) search for and access listing related to this contract and view details,
e) click on Express Interest link.
3) Once you have expressed your interest, please access the My ITTs page, where you can view all the documentation (and download if required) and construct your reply in the bravo online questionnaire, as instructed. The deadline will be detailed in the tender documentation.
For technical support in submitting your ‘Expression of Interest’ or registering on the ‘Bravo Solution’ Electronic Sourcing system please contact the Bravo Solution Helpdesk via Tel: 0800 069 8630 or email: email@example.com.
H.pylori (Helicobacter Pylori) is a bacteria strongly associated with peptic ulcer disease
Eradicating it from these patients reduces recurrence rates.
Eradicating it from patients with non-ulcer dyspepsia reduces symptoms
NICE recommends H.pylori testing and eradication in patients with PUD, NUD and as an intervention for un-investigated dyspepsia
The 13C Urea Breath test is recognized as being the non-invasive test of choice for identifying H pylori
On the basis of convenience and cost, DIABACT UBT is the 13C Urea Breath testing kit of choice.
The test involves the collection of breath samples before and after the ingestion of a 13C Urea tablet. If H-pylori is present in the stomach it produces the enzyme urease, which breaks down the ingested 13C Urea to ammonia and 13CO2. The samples are sent away for laboratory analysis and a result is provided within 48 hours. The post dose breath sample will contain this 13CO2 if H. pylori is present.
Aims and objectives of the Service
Enable appropriate and timely treatment for the management of dyspepsia
Improve the care of patients with dyspepsia symptoms through the provision of a standardised effective and evidence based H. pylori service
Ensure all patients with dyspepsia requiring a H-Pylori test as per NICE guidelines have access to this test in a community setting
Improve access and choice for patients
Ensure that all requests for Endoscopy are appropriate and only those patients with “ALARM” symptoms are referred to secondary care providers. This will prevent unnecessary and inappropriate outpatient attendances which has an emphasis on providing better value for money
Ensure the treatment and review of dyspeptic patients is documented on practice computer systems so that a register of patients with dyspepsia can be produced
This Service has been procured through the Any Qualified Provider route and is a private commercial contractual arrangement between the Service Commissioners and the successful pharmacies that have been awarded the bid.
|List of Pharmacies & GP Surgeries providing the service||to be updated|